NCT00456365View on ClinicalTrials.gov

Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Polycystic Kidney, Autosomal Dominant
Interventions
DRUG

pravastatin

Pravastatin 20 mg daily (subject age 8-12 years) or 40 mg daily (subject age 13-21 years)

DRUG

Placebo

Placebo daily

Trial Locations (1)

80262

University of Colorado at Denver and Health Sciences Center, Denver

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Colorado, Denver

OTHER

NCT00456365 - Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Biotech Hunter | Biotech Hunter